AIGH Capital Management
Latest statistics and disclosures from AIGH Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MRVL, GLW, PSNL, MYO, ARQ, and represent 43.55% of AIGH Capital Management's stock portfolio.
- Added to shares of these 10 stocks: MRVL (+$39M), VSTM (+$14M), BLZE (+$11M), ZVRA (+$6.6M), MYO, COYA, ELUT, Acasti Pharma, XERS, INO.
- Started 7 new stock positions in ZVRA, Acasti Pharma, KALA, VSTM, MRVL, BLZE, INO.
- Reduced shares in these 10 stocks: , APPS (-$14M), GLW (-$7.1M), CLRB (-$6.8M), DCTH, EGRX, MRAM, , ACST, IMMX.
- Sold out of its positions in ACST, CLRB, APPS, EGRX, MRAM, EVOK, IMMX, MX, XBI, SVREW.
- AIGH Capital Management was a net seller of stock by $-70M.
- AIGH Capital Management has $320M in assets under management (AUM), dropping by -9.77%.
- Central Index Key (CIK): 0001835943
Tip: Access up to 7 years of quarterly data
Positions held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for AIGH Capital Management
AIGH Capital Management holds 36 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Marvell Technology (MRVL) | 12.1 | $39M | NEW | 350k | 110.45 |
|
| Corning Incorporated (GLW) | 11.1 | $36M | -16% | 750k | 47.52 |
|
| Personalis Ord (PSNL) | 6.9 | $22M | -5% | 3.8M | 5.78 |
|
| Myomo Com New (MYO) | 6.8 | $22M | +21% | 3.4M | 6.44 |
|
| Advanced Emissions (ARQ) | 6.7 | $21M | 2.8M | 7.57 |
|
|
| Delcath Sys Com New (DCTH) | 5.2 | $17M | -22% | 1.4M | 12.04 |
|
| Scpharmaceuticals (SCPH) | 4.6 | $15M | 4.2M | 3.54 |
|
|
| Verastem Com New (VSTM) | 4.3 | $14M | NEW | 2.7M | 5.17 |
|
| Lightpath Technologies Com Cl A (LPTH) | 4.1 | $13M | 3.7M | 3.53 |
|
|
| Tarsus Pharmaceuticals (TARS) | 3.9 | $12M | +9% | 225k | 55.37 |
|
| Elutia Cl A Com (ELUT) | 3.6 | $12M | +22% | 3.1M | 3.74 |
|
| Backblaze Com Cl A (BLZE) | 3.4 | $11M | NEW | 1.8M | 6.02 |
|
| Biodesix (BDSX) | 3.0 | $9.5M | +8% | 6.2M | 1.53 |
|
| Bk Technologies Corporation Com New (BKTI) | 2.9 | $9.2M | -5% | 268k | 34.29 |
|
| Xeris Pharmaceuticals (XERS) | 2.7 | $8.7M | +17% | 2.6M | 3.39 |
|
| Tela Bio (TELA) | 2.5 | $8.0M | +7% | 2.7M | 3.02 |
|
| Coya Therapeutics Common Stock (COYA) | 2.2 | $6.9M | +84% | 1.2M | 5.73 |
|
| Zevra Therapeutics Com New (ZVRA) | 2.1 | $6.6M | NEW | 789k | 8.34 |
|
| Electrovaya Com New (ELVA) | 2.0 | $6.3M | +3% | 2.5M | 2.48 |
|
| Ideal Pwr Com New (IPWR) | 1.9 | $6.2M | +17% | 823k | 7.55 |
|
| Theratechnologies Com New (THTX) | 1.7 | $5.5M | -18% | 3.0M | 1.81 |
|
| Intellicheck Com New (IDN) | 1.4 | $4.5M | -8% | 1.6M | 2.80 |
|
| Polypid (PYPD) | 0.8 | $2.6M | +21% | 828k | 3.16 |
|
| Acasti Pharma | 0.6 | $2.0M | NEW | 521k | 3.81 |
|
| Franklin Wireless Corporation (FKWL) | 0.6 | $1.9M | 390k | 4.90 |
|
|
| Aprea Therapeutics Com New (APRE) | 0.6 | $1.8M | 539k | 3.28 |
|
|
| In8bio (INAB) | 0.5 | $1.6M | +269% | 6.2M | 0.26 |
|
| Inovio Pharmaceuticals Com Shs (INO) | 0.4 | $1.2M | NEW | 654k | 1.83 |
|
| Biofrontera Com New (BFRI) | 0.3 | $884k | +61% | 811k | 1.09 |
|
| Kiora Pharmaceuticals (KPRX) | 0.3 | $861k | 256k | 3.37 |
|
|
| Kala Bio Com New (KALA) | 0.3 | $842k | NEW | 121k | 6.94 |
|
| Plus Therapeutics (PSTV) | 0.2 | $645k | 561k | 1.15 |
|
|
| Biomx Com New (PHGE) | 0.2 | $632k | 865k | 0.73 |
|
|
| Smartkem Com New (SMTK) | 0.1 | $460k | +16% | 157k | 2.94 |
|
| Beyond Air (XAIR) | 0.1 | $355k | -72% | 992k | 0.36 |
|
| Marchex CL B (MCHX) | 0.1 | $347k | 198k | 1.75 |
|
Past Filings by AIGH Capital Management
SEC 13F filings are viewable for AIGH Capital Management going back to 2020
- AIGH Capital Management 2024 Q4 filed Feb. 12, 2025
- AIGH Capital Management 2024 Q3 filed Nov. 13, 2024
- AIGH Capital Management 2024 Q2 filed Aug. 7, 2024
- AIGH Capital Management 2024 Q1 filed May 14, 2024
- AIGH Capital Management 2023 Q4 filed Feb. 12, 2024
- AIGH Capital Management 2023 Q3 filed Nov. 13, 2023
- AIGH Capital Management 2023 Q2 filed Aug. 14, 2023
- AIGH Capital Management 2023 Q1 filed May 15, 2023
- AIGH Capital Management 2022 Q4 filed Feb. 15, 2023
- AIGH Capital Management 2022 Q3 filed Nov. 14, 2022
- AIGH Capital Management 2022 Q2 filed Aug. 12, 2022
- AIGH Capital Management 2022 Q1 filed May 12, 2022
- AIGH Capital Management 2021 Q4 filed Feb. 10, 2022
- AIGH Capital Management 2021 Q3 filed Nov. 12, 2021
- AIGH Capital Management 2021 Q2 filed Aug. 12, 2021
- AIGH Capital Management 2021 Q1 filed May 13, 2021